U Ozuguz1, S Oruc2, M S Ulu3, H Demirbas2, A Acay3, B Coker3, B Beyazıt2, M Yaman2, T Koken4. 1. Department of Internal Medicine, Endocrinology and Metabolism, Faculty of Medicine, Afyon Kocatepe University, 03200, Afyonkarahisar, Turkey. uozoguz@yahoo.com.tr. 2. Department of Neurology, Faculty of Medicine, Afyon Kocatepe University, 03200, Afyonkarahisar, Turkey. 3. Department of Internal Medicine, Faculty of Medicine, Afyon Kocatepe University, 03200, Afyonkarahisar, Turkey. 4. Department of Biochemistry, Faculty of Medicine, Afyon Kocatepe University, 03200, Afyonkarahisar, Turkey.
Abstract
AIM: The aim of this study was to evaluate the relationship between diabetic peripheral neuropathy (DPN) and vitamin D, nerve growth factor (NGF) and oxidative stress markers in patients with type 1 diabetes. METHODS: Ninety-six patients with type 1 diabetes were included in the study. All patients were evaluated for DPN with Michigan Neuropathy Screening Instrument. Fasting blood glucose, HbA1c, lipid parameters, 25 (OH) D3, NGF, total oxidant status, total antioxidant status and oxidative stress index were measured. RESULTS: Twenty-six patients (27 %) had DPN (group 1) and 70 patients did not have neuropathy (group 2). When the groups were evaluated with respect to general demographic characteristics, no differences were detected. Mean age, duration of diabetes and retinopathy were found significantly higher in patients who had neuropathy. Glomerular filtration rate levels were significantly lower in the neuropathy group. Between the groups, 25 (OH) vitamin D levels were significantly lower in the neuropathy group, while there were no differences in NGF levels or in oxidative stress markers. Michigan neuropathy examination score was positively correlated with age, and diabetes duration was negatively correlated with 25 (OH) vitamin D levels. In addition, 25 (OH) vitamin D was positively correlated with NGF. In the logistic regression analysis to determine the independent variables that will affect the development of neuropathy, duration of diabetes was detected as the only factor (p = 0.039, OR = 1.071). CONCLUSION: It seems that the most important risk factor for the development of neuropathy in type 1 diabetic patients is disease duration.
AIM: The aim of this study was to evaluate the relationship between diabetic peripheral neuropathy (DPN) and vitamin D, nerve growth factor (NGF) and oxidative stress markers in patients with type 1 diabetes. METHODS: Ninety-six patients with type 1 diabetes were included in the study. All patients were evaluated for DPN with Michigan Neuropathy Screening Instrument. Fasting blood glucose, HbA1c, lipid parameters, 25 (OH) D3, NGF, total oxidant status, total antioxidant status and oxidative stress index were measured. RESULTS: Twenty-six patients (27 %) had DPN (group 1) and 70 patients did not have neuropathy (group 2). When the groups were evaluated with respect to general demographic characteristics, no differences were detected. Mean age, duration of diabetes and retinopathy were found significantly higher in patients who had neuropathy. Glomerular filtration rate levels were significantly lower in the neuropathy group. Between the groups, 25 (OH) vitamin D levels were significantly lower in the neuropathy group, while there were no differences in NGF levels or in oxidative stress markers. Michigan neuropathy examination score was positively correlated with age, and diabetes duration was negatively correlated with 25 (OH) vitamin D levels. In addition, 25 (OH) vitamin D was positively correlated with NGF. In the logistic regression analysis to determine the independent variables that will affect the development of neuropathy, duration of diabetes was detected as the only factor (p = 0.039, OR = 1.071). CONCLUSION: It seems that the most important risk factor for the development of neuropathy in type 1 diabeticpatients is disease duration.
Entities:
Keywords:
Nerve growth factor; Neuropathy; Oxidative stress; Type 1 diabetes; Vitamin D
Authors: P J Dyck; K M Kratz; J L Karnes; W J Litchy; R Klein; J M Pach; D M Wilson; P C O'Brien; L J Melton; F J Service Journal: Neurology Date: 1993-04 Impact factor: 9.910
Authors: Vanessa A Diaz; Arch G Mainous; Peter J Carek; Andrea M Wessell; Charles J Everett Journal: J Am Board Fam Med Date: 2009 Sep-Oct Impact factor: 2.657
Authors: Harleen Kaur; Kim C Donaghue; Albert K Chan; Paul Benitez-Aguirre; Stephen Hing; Margaret Lloyd; Janine Cusumano; Alison Pryke; Maria E Craig Journal: Diabetes Care Date: 2011-04-22 Impact factor: 19.112
Authors: Ahmed El-Abd Ahmed; Hala M Sakhr; Mohammed H Hassan; Mostafa I El-Amir; Hesham H Ameen Journal: Diabetes Metab Syndr Obes Date: 2019-05-14 Impact factor: 3.168
Authors: Dan Ziegler; Barbara Thorand; Haifa Maalmi; Christian Herder; Cornelia Huth; Wolfgang Rathmann; Gidon J Bönhof; Margit Heier; Wolfgang Koenig; Michael Roden; Annette Peters Journal: Int J Obes (Lond) Date: 2022-04-26 Impact factor: 5.551